Matt Hancock

In October 2023 I joined the group of Inge Jedema as a Postdoc.

My projects focus on understanding resistance and relapse mechanisms to TIL therapy. I am particularly interested to understand the T cell lifecycle within cancer and understand how it can be modulated to improve therapeutic and patient outcomes.